Pid medicine
Reading Document
Medical Text Search
pelvic inflammatory disease PID antibiotic treatment regimens
Medical Text Search
PID pelvic inflammatory disease diagnosis criteria management outpatient inpatient
GradeResponse
GradeResponse
Pelvic Inflammatory Disease (PID) — Treatment
Diagnosis Criteria (CDC)
Empirical treatment should be initiated in sexually active women at risk for PID who have pelvic or lower abdominal pain with at least one of the following on pelvic exam (Harrison's, p. 4096):
- Cervical motion tenderness
- Uterine tenderness
- Adnexal tenderness
Outpatient vs. Inpatient
The PEACH trial (831 patients) showed equivalent short- and long-term outcomes for outpatient vs. inpatient treatment in mild-to-moderate PID (Harrison's, p. 4096).
Hospitalization should be considered when:
- Diagnosis is uncertain (cannot exclude surgical emergency)
- Tubo-ovarian abscess suspected
- Failure to respond to oral therapy
- Severe illness, nausea/vomiting precluding oral meds
- Pregnancy
Treatment Regimens
Outpatient (Ambulatory) — Preferred
| Drug | Dose |
|---|---|
| Ceftriaxone (covers gonorrhea) | 500 mg IM single dose |
| + Doxycycline (covers chlamydia) | 100 mg PO twice daily × 14 days |
| + Metronidazole (covers anaerobes/BV) | 500 mg PO twice daily × 14 days |
Metronidazole should be strongly considered, especially if bacterial vaginosis or trichomoniasis is present, or if there has been gynecologic instrumentation within the past 3 weeks. A randomized trial confirmed it reduces endometrial anaerobes, Mycoplasma genitalium, and pelvic tenderness (Harrison's, p. 4095).
Inpatient (Parenteral) — Standard Regimen
| Drug | Dose |
|---|---|
| Cefoxitin | 2 g IV every 6 hours |
| + Doxycycline | 100 mg IV/PO every 12 hours |
(Transition to oral doxycycline 100 mg twice daily once clinically improved, to complete 14 days total)
Alternative Parenteral Regimen
| Drug | Dose |
|---|---|
| Clindamycin | 900 mg IV every 8 hours |
| + Gentamicin | 2 mg/kg IV loading, then 1.5 mg/kg every 8 hours (or single daily dosing) |
Key Points
- Duration: 14 days total for all regimens
- Partner treatment: Sexual partners from the past 60 days should be tested and treated empirically for gonorrhea and chlamydia
- IUD: Current guidelines do not mandate IUD removal in women with PID; treatment can proceed with IUD in place
- Follow-up: Reassess within 72 hours; lack of improvement warrants hospitalization and further workup (imaging for abscess)
- M. genitalium: If treatment failure occurs and M. genitalium is suspected, moxifloxacin 400 mg PO daily × 14 days is an option
⚠️ This is clinical reference information. Individual patient management should follow local guidelines and clinical judgment.
This is a shared conversation. Sign in to Orris to start your own chat.